We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current GNMLF market cap is 1.43B. The company's latest EPS is MXN 1.0812 and P/E is 1.32.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| MXN ($) | MXN ($) | MXN ($) | MXN ($) | MXN ($) | |
| Total Revenue | 12.77B | 13.91B | 15.55B | 16.9B | 16.48B |
| Operating Income | 2.41B | 2.83B | 2.96B | 3.29B | 3.2B |
| Net Income | 764.46M | 1.47B | 1.31B | 1.39B | 1.08B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| MXN ($) | MXN ($) | MXN ($) | MXN ($) | MXN ($) | |
| Total Assets | 19.25B | 22.13B | 21.54B | 21.61B | 20.74B |
| Total Liabilities | 11.28B | 12.5B | 11.47B | 11.45B | 11.3B |
| Total Equity | 7.97B | 9.63B | 10.07B | 10.15B | 9.44B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| MXN ($) | MXN ($) | MXN ($) | MXN ($) | MXN ($) | |
| Operating | 1.01B | 1.71B | 1.47B | 2.05B | 2.25B |
| Investing | -844.64M | -663.65M | -765.62M | -282.3M | -302.21M |
| Financing | -621.94M | 189.85M | -1.47B | -1.36B | -1.68B |
| Market Cap | 1.43B |
| Price to Earnings Ratio | 1.32 |
| Price to Sales Ratio | 0.09 |
| Price to Cash Ratio | 0.96 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | 1,144.73% |
| Shares Outstanding | 1B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 300 |
| 52 Week Change | 81.01% |
| 52 Week High | 1.43 |
| 52 Week Low | 0.79 |
| Spread (Intraday) | 0.31 (21.53%) |
| Company Name | Genoma Lab International SAB DE CV (PK) |
| Address |
avenida antonio dovali jaime no. 70, torre a,piso 2 mexico city, distrito federal 01210 |
| Website | https://www.genommalab.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
